-
Anders KL, Nguyet NM, Chau NV, Hung NT, Thuy TT, Farrar J, Wills B, Hien TT, Simmons CP, 2011: Epidemiological factors associated with dengue shock syndrome and mortality in hospitalized dengue patients in Ho Chi Minh City, Vietnam[J]. Am J Trop Med Hyg, 84, 127-134. doi: 10.4269/ajtmh.2011.10-0476
-
Ashburn PM, Caraig CF, 1907: Experimental investigations regarding the etiology of dengue fever[J]. J Infect Dis, 4, 440-475. doi: 10.1093/infdis/4.3.440
-
Bachal R, Alagarasu K, Singh A, Salunke A, Shah P, Cecilia D, 2015: Higher levels of dengue-virus-specific IgG and IgA during predefervescence associated with primary dengue hemorrhagic fever[J]. Arch Virol, 160, 2435-2443. doi: 10.1007/s00705-015-2519-7
-
Barber C, Kalicinsky C, 2016: A novel combination of an IgE mediated adult onset food allergy and a suspected mast cell activation syndrome presenting as anaphylaxis[J]. Allergy Asthma Clin Immunol, 12, 46-. doi: 10.1186/s13223-016-0151-z
-
Begg CB, Mazumdar M, 1994: Operating characteristics of a rank correlation test for publication bias[J]. Biometrics, 50, 1088-1101. doi: 10.2307/2533446
-
Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O, 2013: The global distribution and burden of dengue[J]. Nature, 496, 504-. doi: 10.1038/nature12060
-
Boesiger J, Tsai M, Maurer M, Yamaguchi M, Brown LF, Claffey KP, Dvorak HF, Galli SJ, 1998: Mast cells can secrete vascular permeability factor/vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of fc epsilon receptor I expression[J]. J Exp Med, 188, 1135-1145. doi: 10.1084/jem.188.6.1135
-
Brown JM, Wilson TM, Metcalfe DD, 2008: The mast cell and allergic diseases: role in pathogenesis and implications for therapy[J]. Clin Exp Allergy, 38, 4-18.
-
Butthep P, Chunhakan S, Yoksan S, Tangnararatchakit K, Chuansumrit A, 2012: Alteration of cytokines and chemokines during febrile episodes associated with endothelial cell damage and plasma leakage in dengue hemorrhagic fever[J]. Pediatr Infect Dis J, 31, e232-e238. doi: 10.1097/INF.0b013e31826fd456
-
Chaturvedi UC, Agarwal R, Elbishbishi EA, Mustafa AS, 2000: Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis[J]. FEMS Immunol Med Microbiol, 28, 183-188. doi: 10.1111/j.1574-695X.2000.tb01474.x
-
Chen CH, Huang YC, Kuo KC, Li CC, 2017: Clinical features and dynamic ordinary laboratory tests differentiating dengue fever from other febrile illnesses in children[J]. J Microbiol Immunol Infect, 51, 614-620.
-
Conroy AL, Gélvez M, Hawkes M, Rajwans N, Tran V, Liles WC, Villar-Centeno LA, Kain KC, 2015: Host biomarkers are associated with progression to dengue haemorrhagic fever: a nested case-control study[J]. Int J Infect Dis, 40, 45-53. doi: 10.1016/j.ijid.2015.07.027
-
Cordeiro MT, Schatzmayr HG, Nogueira RM, Oliveira VF, Melo WT, Carvalho EF, 2007: Dengue and dengue hemorrhagic fever in the State of Pernambuco, 1995-2006[J]. Rev Soc Bras Med Trop, 40, 605-611. doi: 10.1590/S0037-86822007000600001
-
Deen JL, Harris E, Wills B, Balmaseda A, Hammond SN, Rocha C, Dung NM, Hung NT, Hien TT, Farrar JJ, 2006: The WHO dengue classification and case definitions: time for a reassessment[J]. Lancet, 368, 170-173. doi: 10.1016/S0140-6736(06)69006-5
-
Deparis X, Murgue B, Roche C, Cassar O, Chungue E, 1998: Changing clinical and biological manifestations of dengue during the dengue-2 epidemic in French Polynesia in 1996/97- description and analysis in a prospective study[J]. Trop Med Int Health, 3, 859-865. doi: 10.1046/j.1365-3156.1998.00319.x
-
Ezeamuzie C, Al-Ali S, Al-Dowaisan A, Khan M, Hijazi Z, Thomson M, 1999: Reference values of total serum IgE and their significance in the diagnosis of allergy among the young adult Kuwaiti population[J]. Clin Exp Allergy, 29, 375-381. doi: 10.1046/j.1365-2222.1999.00463.x
-
Fahy JV, 2015: Type 2 inflammation in asthma [mdash] present in most, absent in many[J]. Nat Rev Immunol, 15, 57-65. doi: 10.1038/nri3786
-
Ferreira GL, 2012: Global dengue epidemiology trends[J]. Rev Inst Med Trop São Paulo, 54, 5-6.
-
Figueiredo MAA, Rodrigues LC, Barreto ML, Lima JWO, Costa MC, Morato V, Blanton R, Vasconcelos PF, Nunes MR, Teixeira MG, 2010: Allergies and diabetes as risk factors for dengue hemorrhagic fever: results of a case control study[J]. PLoS Negl Trop Dis, 4, e699-. doi: 10.1371/journal.pntd.0000699
-
Flipse J, Diosa-Toro MA, Hoornweg TE, Van De Pol DP, UrcuquiInchima S, Smit JM, 2016: Antibody-dependent enhancement of dengue virus infection in primary human macrophages; balancing higher fusion against antiviral responses[J]. Sci Rep, 6, 29201-. doi: 10.1038/srep29201
-
Furuta T, Murao LA, Lan NT, Huy NT, Huong VT, Thuy TT, Tham VD, Nga CT, Ha TT, Ohmoto Y, Kikuchi M, Morita K, Yasunami M, Hirayama K, Watanabe N, 2012: Association of mast cell-derived VEGF and proteases in Dengue shock syndrome[J]. PLoS Negl Trop Dis, 6, e1505-. doi: 10.1371/journal.pntd.0001505
-
Gibbons RV, Vaughn DW, 2002: Dengue: an escalating problem[J]. BMJ, 324, 1563-1566. doi: 10.1136/bmj.324.7353.1563
-
Gonzalez-de-Olano D, Alvarez-Twose I, 2018: Mast cells as key players in allergy and inflammation[J]. J Invest Allergol Clin Immunol, 28, 365-378. doi: 10.18176/jiaci.0327
-
Guha-Sapir D, Schimmer B, 2005: Dengue fever: new paradigms for a changing epidemiology[J]. Emerg Themes Epidemiol, 2, 1-. doi: 10.1186/1742-7622-2-1
-
Guzmán MG, Kouri G, 1996: Advances in dengue diagnosis[J]. Clin Diagn Lab Immunol, 3, 621-. doi: 10.1128/CDLI.3.6.621-627.1996
-
Health NIo (2014) Quality assessment tool for observational cohort and cross-sectional studies. National Heart, Lung, and Blood Institute. http://www.nhlbi.nihgov/health-pro/guidelines/indevelop/cardiovascular-risk-reduction/tools/cohort. Accessed 5 Nov 2015
-
Higgins JPT, Thompson SG, Deeks JJ, Altman DG, 2003: Measuring inconsistency in meta-analyses[J]. BMJ, 327, 557-560. doi: 10.1136/bmj.327.7414.557
-
Huedo-Medina TB, Sanchez-Meca J, Marin-Martinez F, Botella J, 2006: Assessing heterogeneity in meta-analysis: Q statistic or I2 index?[J]. Psychol Methods, 11, 193-206. doi: 10.1037/1082-989X.11.2.193
-
Kamath SR, Ranjit S, 2006: Clinical features, complications and atypical manifestations of children with severe forms of dengue hemorrhagic fever in South India[J]. Indian J Pediatr, 73, 889-895. doi: 10.1007/BF02859281
-
Kao J-H, Chen C-D, Li Z-RT, Chan T-C, Tung T-H, Chu Y-H, Cheng H-Y, Liu J-W, Shih F-Y, Shu P-Y, 2016: The critical role of early dengue surveillance and limitations of clinical reportingimplications for non-endemic countries[J]. PLoS ONE, 11, e0160230-. doi: 10.1371/journal.pone.0160230
-
Khabiri A, Bagheri F, Assmar M, Siavashi M, 2006: Analysis of specific IgE and IgG subclass antibodies for diagnosis of Echinococcus granulosus[J]. Parasite Immunol, 28, 357-362. doi: 10.1111/j.1365-3024.2006.00837.x
-
Koraka P, Murgue B, Deparis X, Setiati TE, Suharti C, van Gorp EC, Hack CE, Osterhaus AD, Groen J, 2003: Elevated levels of total and dengue virus-specific immunoglobulin E in patients with varying disease severity[J]. J Med Virol, 70, 91-98. doi: 10.1002/jmv.10358
-
Kurane I, Rothman AL, Livingston PG, Green S, Gagnon SJ, Janus J, Innis BL, Nimmannitya S, Nisalak A, Ennis FA, 1994: Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome[J]. Arch Virol Suppl, 9, 59-64.
-
Leung A, Heal C, Perera M, Pretorius C, 2015: A systematic review of patient-related risk factors for catheter-related thrombosis[J]. J Thromb Thrombolysis, 40, 363-373. doi: 10.1007/s11239-015-1175-9
-
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D, 2009: The PRISMA statement for reporting systematic reviews and metaanalyses of studies that evaluate health care interventions: explanation and elaboration[J]. PLoS Med, 6, e1000100-. doi: 10.1371/journal.pmed.1000100
-
Low JG, Ong A, Tan LK, Chaterji S, Chow A, Lim WY, Lee KW, Chua R, Chua CR, Tan SW, 2011: The early clinical features of dengue in adults: challenges for early clinical diagnosis[J]. PLoS Negl Trop Dis, 5, e1191-. doi: 10.1371/journal.pntd.0001191
-
Mabalirajan U, Kadhiravan T, Sharma S, Banga A, Ghosh B, 2005: Th2 immune response in patients with dengue during defervescence: preliminary evidence[J]. Am J Trop Med Hyg, 72, 783-785. doi: 10.4269/ajtmh.2005.72.783
-
Mahmood S, Hafeez S, Nabeel H, Zahra U, Nazeer H, 2013: Does comorbidity increase the risk of dengue hemorrhagic fever and dengue shock syndrome?[J]. ISRN Trop Med, 2013, 5-. doi: 10.1155/2013/139273.139273
-
Míguez-Burbano MJ, Jaramillo CA, Palmer CJ, Shor-Posner G, Velásquez LS, Lai H, Baum MK, 1999: Total immunoglobulin E levels and dengue infection on San Andres Island, Colombia[J]. Clin Diagn Lab Immunol, 6, 624-626. doi: 10.1128/CDLI.6.4.624-626.1999
-
Mims JW, 2015: Asthma: definitions and pathophysiology[J]. Int Forum Allergy Rhinol, 5, S2-S6. doi: 10.1002/alr.21609
-
Munafo MR, Flint J, 2004: Meta-analysis of genetic association studies[J]. Trends Genet, 20, 439-444. doi: 10.1016/j.tig.2004.06.014
-
Ndii MZ, Allingham D, Hickson R, Glass K, 2016: The effect of Wolbachia on dengue outbreaks when dengue is repeatedly introduced[J]. Theor Popul Biol, 111, 9-15. doi: 10.1016/j.tpb.2016.05.003
-
Organization WH, Research SPf, Diseases TiT, Diseases WHODoCoNT, Epidemic WHO, Alert P (2009) Dengue: guidelines for diagnosis, treatment, prevention and control. World Health Organization, Geneva
-
Pang J, Salim A, Lee VJ, Hibberd ML, Chia KS, Leo YS, Lye DC, 2012: Diabetes with hypertension as risk factors for adult dengue hemorrhagic fever in a predominantly dengue serotype 2 epidemic: a case control study[J]. PLoS Negl Trop Dis, 6, e1641-. doi: 10.1371/journal.pntd.0001641
-
Pang X, Zhang R, Cheng G, 2017: Progress towards understanding the pathogenesis of dengue hemorrhagic fever[J]. Virol Sin, 32, 16-22. doi: 10.1007/s12250-016-3855-9
-
Passos S, Bedoya S, Hökerberg Y, Maia S, Georg I, Nogueira R, Souza R, Marzochi K, 2008: Clinical and laboratory signs as dengue markers during an outbreak in Rio de Janeiro[J]. Infection, 36, 570-. doi: 10.1007/s15010-008-7334-6
-
Pavri K, Sheikh B, Ghosh S, Chodankar V, 1977: Immunoglobulin E in sera of patients of dengue haemorrhagic fever[J]. Indian J Med Res, 66, 537-543.
-
Pavri K, Swe T, Ramamoorthy C, Chodankar V, 1979: Immunoglobulin E in dengue haemorrhagic fever (DHF) cases[J]. Trans R Soc Trop Med Hyg, 73, 451-452. doi: 10.1016/0035-9203(79)90174-3
-
Potenzieri C, Undem BJ, 2012: Basic mechanisms of itch[J]. Clin Exp Allergy, 42, 8-19. doi: 10.1111/j.1365-2222.2011.03791.x
-
Renke J, Kędzierska-Mieszkowska S, Lange M, Nedoszytko B, Wasilewska E, Liberek A, Renke M, Niedoszytko M, Witkowski J, Skórko-Glonek J, Lipińska B, 2019: Mast cells in mastocytosis and allergy—important player in metabolic and immunological homeostasis[J]. Adv Med Sci, 64, 124-130. doi: 10.1016/j.advms.2018.08.013
-
Rigau-Perez JG, 2006: Severe dengue: the need for new case definitions[J]. Lancet Infect Dis, 6, 297-302. doi: 10.1016/S1473-3099(06)70465-0
-
Rubio DG, Peraza OC, Delgado FR, Ramírez DP, Martínez MG, Rodríguez AM, Bada NR, Guzmán Tirado MG, 2008: Description of dengue hemorrhagic fever, serotype 3, City of Havana, 2001-2002[J]. Rev Cubana Med Trop, 60, 1-.
-
Rush B, 1951: An account of the bilious remitting fever: as it appeared in philadelphia, in the summer and autumn of the year 1780[J]. Am J Med, 11, 546-550. doi: 10.1016/0002-9343(51)90035-6
-
Sanchez LF, Hotta H, Hotta S, Homma M, 1986: Degranulation and histamine release from murine mast cells sensitized with dengue virus-immune sera[J]. Microbiol Immunol, 30, 753-759. doi: 10.1111/j.1348-0421.1986.tb03002.x
-
Schmidt AC, Lin L, Martinez LJ, Ruck RC, Eckels KH, Collard A, De La Barrera R, Paolino KM, Toussaint J-F, Lepine E, 2017: Phase 1 randomized study of a tetravalent dengue purified inactivated vaccine in healthy adults in the United States[J]. Am J Trop Med Hyg, 96, 1325-1337. doi: 10.4269/ajtmh.16-0634
-
Simmons CP, Farrar JJ, 2012: Current concepts[J]. N Engl J Med, 366, 1423-1432. doi: 10.1056/NEJMra1110265
-
Syenina A, Jagaraj CJ, Aman SA, Sridharan A, St John AL, 2015: Dengue vascular leakage is augmented by mast cell degranulation mediated by immunoglobulin Fcgamma receptors[J]. Elife, 4, e05291-. doi: 10.7554/eLife.05291
-
Teixeira MG, Paixão ES, Maria da Conceição NC, Cunha RV, Pamplona L, Dias JP, Figueiredo CA, Figueiredo MAA, Blanton R, Morato V, 2015: Arterial hypertension and skin allergy are risk factors for progression from dengue to dengue hemorrhagic fever: a case control study[J]. PLoS Negl Trop Dis, 9, e0003812-. doi: 10.1371/journal.pntd.0003812
-
Tuchinda M, Dhorranintra B, Tuchinda P, 1977: Histamine content in 24-hour urine in patients with dengue haemorrhagic fever[J]. Southeast Asian J Trop Med Public Health, 8, 80-83.
-
Vasconcelos P, Lima J, Da Rosa A, Timbo M, da Rosa E, Lima H, Rodrigues S, da Rosa J, 1998: Dengue epidemic in Fortaleza, Ceara: randomized seroepidemiologic survey[J]. Rev Saude Publica, 32, 447-454. doi: 10.1590/S0034-89101998000500007
-
Vazquez S, Perez A, Ruiz D, Rodriguez R, Pupo M, Calzada N, González L, González D, Castro O, Serrano T, 2005: Serological markers during dengue 3 primary and secondary infections[J]. J Clin Virol, 33, 132-137. doi: 10.1016/j.jcv.2004.10.013
-
Vazquez S, Lozano C, Perez AB, Castellanos Y, Ruiz D, Calzada N, Guzmán MG, 2014: Dengue specific immunoglobulins M, A, and E in primary and secondary dengue 4 infected Salvadorian children[J]. J Med Virol, 86, 1576-1583. doi: 10.1002/jmv.23833
-
Yaqoob P, Calder PC, 1998: Cytokine production by human peripheral blood mononuclear cells: differential senstivity to glutamine availability[J]. Cytokine, 10, 790-794. doi: 10.1006/cyto.1998.0358